First Time Loading...

CSL Ltd
ASX:CSL

Watchlist Manager
CSL Ltd Logo
CSL Ltd
ASX:CSL
Watchlist
Price: 275.8 AUD 0.15% Market Closed
Updated: May 5, 2024

CSL Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CSL Ltd
Revenue Peer Comparison

Comparables:
IMM
MSB
CUV
TLX
PYC

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
CSL Ltd
ASX:CSL
Revenue
$14.2B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
10%
Immutep Ltd
ASX:IMM
Revenue
AU$256.6k
CAGR 3-Years
-61%
CAGR 5-Years
-45%
CAGR 10-Years
-24%
Mesoblast Ltd
ASX:MSB
Revenue
$7.5m
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Revenue
AU$87.3m
CAGR 3-Years
31%
CAGR 5-Years
25%
CAGR 10-Years
42%
Telix Pharmaceuticals Ltd
ASX:TLX
Revenue
AU$502.5m
CAGR 3-Years
359%
CAGR 5-Years
381%
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Revenue
AU$21.5m
CAGR 3-Years
99%
CAGR 5-Years
377%
CAGR 10-Years
32%

See Also

What is CSL Ltd's Revenue?
Revenue
14.2B USD

Based on the financial report for Dec 31, 2023, CSL Ltd's Revenue amounts to 14.2B USD.

What is CSL Ltd's Revenue growth rate?
Revenue CAGR 10Y
10%

Over the last year, the Revenue growth was 21%. The average annual Revenue growth rates for CSL Ltd have been 12% over the past three years , 11% over the past five years , and 10% over the past ten years .